Orakl Oncology has developed a first-in-class AI-powered techbio platform that combines real-world patient data with cutting-edge biology into a unique and integrated decision-making engine for the entire drug development process.
This technology delivers best-in-class predictions to improve the recruitment of responding patients and clinical trial probability of success. Discover our two first AI-powered commercial solutions to reinvent oncology drug development:
Orakl Oncology has developed a first-in-class AI-powered techbio platform that combines real-world patient data with cutting-edge biology into a unique and integrated decision-making engine for the entire drug development process.
This technology delivers best-in-class predictions to improve the recruitment of responding patients and clinical trial probability of success. Discover our two first AI-powered commercial solutions to reinvent oncology drug development.
O-Predict
Forecast patient responses to new drug candidates, predict key clinical outcomes such as the number of responders and progression-free survival.
*Gryspeert et al., ESMO, 2024
Forecast patient responses to new drug candidates, predict key clinical outcomes such as the number of responders and PFS.
Forecast patient responses to new drug candidates, predict key clinical outcomes such as the number of responders and progression-free survival.
O-Validate
Generate biological evidence of causality, supporting target and biomarker validation and enabling data-based strategic decision-making across drug development stages.
Orakl Oncology's large collection of tumor avatars captures cancer heterogeneity across patients. Each patient tumor avatar combines a biological and digital component and the Orakl platform is driven by lab automation and AI-based analysis.
Best-in-class biology
Best-in-class biology
Best-in-class biology
Our tumour models mimic real-life responses to drugs. They result from the exclusive know-how from more than 28 years of combined R&D.
Deep patient data
Deep patient data
Deep patient data
We match our tumour models with detailed clinical and omics data for each patients. This provides the necessary context to interpret biological results.
AI-powered analysis
AI-powered analysis
AI-powered analysis
We gather unique insights by mining multi-modal experimental data and combining it with deep patient data.
